Pathos AI, ( a clinical-stage biotechnology company focused on re-engineering drug development through artificial intelligence, announced the first patient has been dosed in the Company’s Phase 1b/2a ...

Future Oncol. 2010;6(5):665-679. Three Phase I studies by O'Donnell and colleagues have reported the pharmacodynamic activity of abiraterone acetate, which was originally developed as an oral ...

A cancer charity has said it is "angry and frustrated" that ministers and health officials have not approved the provision of ...

Abiraterone acetate (CB7630), a pregnenolone analog, is an orally administered small molecule that irreversibly inhibits a rate-limiting enzyme in androgen biosysnthesis, CYP17, and blocks the ...

Triple therapy with darolutamide vs abiraterone for metastatic hormone-sensitive prostate cancer is associated with better clinical outcomes. Triplet therapy that includes darolutamide vs ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Eberle, R.Ph., M.B.A. "We've secured volume discounts for our abiraterone product that we are passing along to our members and to patients. This price reduction is proof that our model is working." ...

Cedric Pobel, MD, covers the PEACE-1 trial of radiotherapy, standard of care, and abiraterone in low-volume metastatic castration-sensitive prostate cancer.

Trials have shown abiraterone can stop prostate cancer from spreading and it can extend the lives of those with the disease.

The charity’s much-loved events, which raise funds for life-saving research, are returning to Wigan. Anyone who joins between ...

People are being invited to step into spring by signing up for Cancer Research UK’s Race for Life in Doncaster.